SCHEMBL23319183

SCHEMBL23319183

c1ccc(-c2cc(-c3cc(-c4ccccc4)cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3)cc(-c3ccc4c(c3)oc3ccccc34)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.44
MMP13 P45452 1/20 0.44
AHR P35869 2/20 0.44
HCRTR1 O43613 1/20 0.43
HPGD P15428 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 4/20 0.42
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
PLA2G2A P14555 4/20 0.42
PLA2G4A P47712 4/20 0.42
TTR P02766 1/20 0.40
PLA2G10 O15496 1/20 0.40
ATM Q13315 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21108868 1.00 MMP12 (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL21029049 1.00 MMP12 (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL21108869 1.00 MMP12 (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL17425689 1.00 MMP12 (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL17425504 1.00 MMP12 (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL20991445 1.00 MMP12 (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL21108867 1.00 MMP12 (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL20991446 0.98 PLA2G2A (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL20991449 0.98 PLA2G2A (0.44) MMP12MMP13AHRHCRTR1HPGD
SCHEMBL25646024 0.98 PLA2G2A (0.44) MMP12MMP13AHRHCRTR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220407012-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE SOULBRAIN CO., LTD. (KR) 2022-12-22 US disclosed
WO-2021086143-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE 솔브레인 주식회사 2021-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407012-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE OCIAD1, AOX1, OXER1 MMP12 3756/4885MMP13 4809/4885AHR 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.